A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast Cancer

NCT00938652 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
519
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi